Concepedia

Clorinda Schettino

CS

2

Publications

85

Citations

2

H-Index

2020

Active since

Affiliations

University of Campania "Luigi Vanvitelli"(Current)

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Istituti di Ricovero e Cura a Carattere Scientifico

Clorinda Schettino is an author at University of Campania "Luigi Vanvitelli" specializing in medicine, obstetrics, and clinical trials.

Top concepts

MedicineOncologyGynecologyCancer TherapyRadiation OncologyGynecology OncologyHealthCovid-19EpidemiologyInflammation

Publications per year

2020–2023

2

Publications

2

Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial

Sandro Pignata, Giovanni Scambia, Clorinda Schettino et al. · The Lancet Oncology · 2023 · 46 citations

Medicine, Cancer Management, Mito End-3 +7

Tocilizumab for patients with COVID-19 pneumonia. The TOCIVID-19 prospective phase 2 trial

Francesco Perrone, Maria Carmela Piccirillo, Paolo A. Ascierto et al. · 2020 · 39 citations · Full text

Abstract Background Tocilizumab, Lethality Rates, Validation Dataset +16

Rows per page

1–2 of 2